Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 191

Results For "ENT"

10011 News Found

GSK launches once daily, single inhaler-triple therapy for COPD patients
Drug Approval | April 26, 2022

GSK launches once daily, single inhaler-triple therapy for COPD patients

Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers


Differentiation based on innovation is the way forward: S Aparna
News | April 26, 2022

Differentiation based on innovation is the way forward: S Aparna

Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'


Biocytogen signs RenMab/RenLite licensing agreement with BeiGene
Biotech | April 26, 2022

Biocytogen signs RenMab/RenLite licensing agreement with BeiGene

In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)


Global AYUSH meet ends with promise of Rs 9000 cr. in investment
News | April 25, 2022

Global AYUSH meet ends with promise of Rs 9000 cr. in investment

Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal


Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours
Biotech | April 25, 2022

Porton Advanced and Sinorda Biomedicine collaborate for cell therapy development for solid tumours

Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine


New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19
Biotech | April 25, 2022

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19

Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment


Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent
Biotech | April 25, 2022

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent

Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction


CanSinoBIO rebrands to reflect commitment to life sciences research
Biotech | April 25, 2022

CanSinoBIO rebrands to reflect commitment to life sciences research

This is the first major brand refresh of CanSinoBIO since its inception in 2009


GOQii to foray into UK patient care with GBP 10 million investment
Startup | April 25, 2022

GOQii to foray into UK patient care with GBP 10 million investment

Partnership with Modality, award-winning GP super partnership


Twenty eight companies commit to Rs 6000 crore at Global Ayush meet
News | April 23, 2022

Twenty eight companies commit to Rs 6000 crore at Global Ayush meet

The commitment is expected to generate over 5.56 lakh jobs and positively impact the lives of more than 76 lakh people, the ministry said